![]() |
市場調查報告書
商品編碼
1496006
全球骨水泥市場:2024-2029 年預測Global Bone Cement Market - Forecasts from 2024 to 2029 |
骨水泥市場預計在預測期內將以 5.67% 的複合年成長率成長,從 2022 年的 17.8 億美元增至 2029 年的 26.19 億美元。
骨水泥是指將聚甲基丙烯酸甲酯(PMMA)、磷酸鈣、玻璃聚鏈烯酸酯等粉末與液態單體混合而成的合成生物材料。這種水泥具有超強的黏合性能,可應用於髖關節、膝關節和關節關節重建等整形外科手術。自癒特性和作為人工關節的功能正在推動醫療領域對骨水泥的需求。
災難性傷害、事故、整形外科手術生產者數量的增加,加上人口老化的加劇,正在為骨水泥市場創造進一步的成長機會。例如,根據美國勞工統計局提供的資料,2019年美國發生的致命工傷事故為5,333起,比2015年發生的4,836起大幅增加10.3%。
隨著此類死亡人數的增加,骨水泥在治療所有骨骼相關損傷中的使用範圍也在擴大,從而推動了預測期內骨水泥市場的需求和成長。市場區隔分為聚甲基丙烯酸甲酯、磷酸鈣、玻璃聚鏈烯酸酯。在骨水泥市場的預測期內,聚甲基丙烯酸甲酯領域預計將出現相對較高的成長率。
聚甲基丙烯酸甲酯機械強度高、毒性低、自硬化性能好,非常適合人工關節的固定。因此,PMMA骨水泥可作為骨骼和植入之間的空間填充物,改善植入的固定。聚丙烯酸甲酯骨水泥的高性能,加上其成本效益和高耐用性,預計將推動未來人工關節手術的需求,從而帶動預測期內同一細分市場的成長以及整體市場的成長。你。
骨水泥在整形外科手術中具有很高的適用性,用人造骨取代受損的骨部分,並使用骨水泥將人造骨固定指定。由於關節和骨骼疼痛、骨關節炎和交通事故的增加,尤其是老年人的整形外科手術數量每年都在顯著增加。例如,根據美國整形外科學會的年度報告,2021年美國進行了240萬例膝關節和關節重建,2021年美國總共置換術。比,增加了18.3%。
此外,根據澳洲整形外科協會國家關節置換手術登記處2022年年度報告,2021年澳洲報告的關節重建總數為185萬例,其中膝關節關節重建手術佔最大佔有率,為68,466例,其次是髖關節置換手術。置換術為 52,787 例。與2020年關節關節重建手術總數相比,2021年關節關節重建手術的整體成長率為7.6%。
隨著整形外科手術數量的增加,作為骨間隙填充材的骨水泥的需求和消耗預計也會增加,這為預測期內骨水泥市場的成長帶來了積極的前景。然而,骨水泥製備的巨大成本加上植入併發症將阻礙預測期內全球水泥市場的成長。
骨水泥市場是由經常需要整形外科干預的運動傷害的增加所推動的。骨水泥,也稱為聚甲基丙烯酸甲酯,用於關節重建手術中以將植入固定到骨頭上。全世界擴大參與體育運動和身體活動,導致與運動相關的傷害增加,特別是那些影響骨骼和關節的傷害。
骨水泥技術的進步,例如用於預防感染疾病和改善生物相容性的抗生素水泥,使其成為各種整形外科應用的首選。隨著人口老化和人們越來越重視保持積極的生活方式,退化性關節疾病和運動相關損傷的盛行率增加,從而增加了對整形外科手術的需求。
使用骨水泥的整形外科手術來支持復健並允許個人恢復活動能力和功能。受運動傷害影響,骨水泥市場預計將繼續擴大。
骨水泥開發是一個成本高且耗時的過程,需要大量的研發投資。 FDA 對外科整形外科水泥的嚴格核准程序推遲了新產品的發布。 FDA 正在要求更多有關安全性和有效性的臨床資料,這將需要進一步的研發投資。儘管有先進的水泥,但仍尋求具有必要臨床資料的具有成本效益的選擇,這影響了市場的生存。骨釘和整形外科釘等替代品也阻礙了先進骨水泥的普及。
The global bone cement market is expected to grow at a CAGR of 5.67% over the forecast period to reach US$2.619 billion by 2029 from US$1.780 billion in 2022.
Bone cement refers to a synthetic biomaterial obtained from mixing polymethyl methacrylate (PMMA), calcium phosphate, or glass polyalkenoate powder with a liquid monomer. The cement has a super gluing feature owing to which it has high applicability in orthopedical surgical procedures such as hip, knee, and joint replacement. The self-healing nature and the ability to work as artificial joints are what drives the demand for bone cement in the medical field.
The growing prevalence of fatal injuries, accidents, and orthopedical surgical producers, coupled with the rising old age population, has provided more growth opportunities to the global bone cement market. For instance, according to the data provided by the US Bureau of Labor Statistics, in 2019, the number of fatal work injuries that occurred in the US stood at 5,333, which showed a significant increase of 10.3% in comparison to the 4,836 injuries that occurred in 2015.
With such an increase in fatal injuries, the scope of bone cement usage for the treatment of any bone-related injury also increases, thereby boosting the market demand and growth of the global bone cement market during the forecast period. The global bone cement market is segmented into polymethyl methacrylate, calcium phosphate, and glass polyalkenoate. The polymethyl methacrylate segment is expected to grow at a relatively higher rate during the forecast period of the global bone cement market.
Polymethyl Methacrylate has rich mechanical strength, minimal toxicity, and provides improved self-curing properties owing to which it has high applicability during joint prostheses fixation. Hence, acting as a space filler between the bone and the implant, PMMA bone cement improves the fixation of the implant. The high-performance features of polymethyl acrylate bone cement, coupled with its cost-effectiveness and high durability, are expected to increase its demand for joint prostheses surgeries in the future, thereby boosting its segment growth as well as the overall global bone cement market growth during the forecast period.
Bone cement has high applicability in orthopedical surgical procedures where the damaged bone part is replaced with a prosthesis, and to hold the prosthesis in its place, bone cement is used. The number of orthopedical surgical procedures has shown a significant increase over the years owing to the growing number of joint & bone pain in people, especially in old age, coupled with growing cases of osteoarthritis and road accidents. For instance, according to the annual report by the American Academy of Orthopedic Surgeons, in 2021, the number of knee and hip bone replacement surgeries stood at 2.4 million in the US, which showed an increase of 18.3% in comparison to the number of surgical procedures conducted in 2020.
Furthermore, according to the 2022 annual report of the Australia Orthopaedic Association National Joint Replacement Surgery Registry, in 2021, the total number of joint replacement surgeries reported in 2021 Australia stood at 1.85 million, of which knee replacement held the largest share of 68,466, followed by hips replacement with 52,787. The overall increase in joint replacement surgeries in 2021 was 7.6% in comparison to 2020's joint replacement surgical volume.
With such an increase in the number of orthopedic surgical procedures, the demand and consumption of bone cement to act as a gap filler in bones are also anticipated to increase, thereby providing a positive outlook for the global bone cement market growth during the forecast period. However, the extensive cost incurred in preparing bone cement coupled with implant complications is projected to hamper the global cement market growth during the forecast period.
The bone cement market is driven by the increasing number of sports injuries, which often require orthopedic interventions. Bone cement, also known as polymethylmethacrylate, is used in joint replacement procedures to anchor implants to the bone. The global increase in sports participation and physical activities has led to an increase in sports-related injuries, particularly those affecting bones and joints.
Advancements in bone cement technology, such as antibiotic-loaded cement to prevent infections or improved biocompatibility, make it a preferred choice in various orthopedic applications. The aging population and increased emphasis on maintaining an active lifestyle result in a higher prevalence of degenerative joint conditions and sports-related injuries, driving the demand for orthopedic procedures.
Orthopedic procedures involving bone cement can support rehabilitation, allowing individuals to regain mobility and function. The global bone cement market expansion is expected to continue due to the impact of sports injuries.
The development of bone cement is a costly and time-consuming process that requires significant R&D investments. The FDA's stringent approval process for surgical orthopedic cement delays new product releases. The FDA demands more clinical data for safety and efficacy, resulting in additional R&D investments. Despite advanced cements, there is still a need for cost-effective options with required clinical data, affecting market survival. Alternatives like bone staples and orthopedic pins also hinder the uptake of advanced bone cement.